Monday 23 March 2020

Veterinary Pain Management Market on Massive Growth at CAGR 8.2% by 2023 | Global Industry Size, Share, Analysis Report 2023

Veterinary Pain Management Market Information: By Drug Type (Opioids), Devices (Laser Therapy Devices), Route of Administration (Oral) Animal Type (Companion Animals) Application (Joint Pain) and End-User (Hospitals & Clinics) – Global Forecast Till 2023
Market Highlights:
Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.
Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).
Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.
Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.
Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.
On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.
Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.
Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.
Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -
By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.
By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.
By Route of Administration: Oral, Parenteral, and Topical among others. 
By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.
By Application: Joint Pain, Postoperative Pain, and Cancer among others.
By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  
By Regions:  Europe, North America, APAC and the Rest-of-the-World.
Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 
Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.
Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.
The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.
The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.
Industry/ Innovation/ Related News:
November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,

CAGR 8.2% Growth Predicted in Veterinary Pain Management Market by 2023 with Top Leading Players and Technology

Veterinary Pain Management Market Information: By Drug Type (Opioids), Devices (Laser Therapy Devices), Route of Administration (Oral) Animal Type (Companion Animals) Application (Joint Pain) and End-User (Hospitals & Clinics) – Global Forecast Till 2023
Market Highlights:
Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.
Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).
Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.
Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.
Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.
On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.
Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.
Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.
Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -
By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.
By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.
By Route of Administration: Oral, Parenteral, and Topical among others. 
By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.
By Application: Joint Pain, Postoperative Pain, and Cancer among others.
By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  
By Regions:  Europe, North America, APAC and the Rest-of-the-World.
Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 
Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.
Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.
The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.
The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.
Industry/ Innovation/ Related News:
November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Cardiovascular Application Market: Worldwide Insight & Projection, Growth and Opportunities 2019-2023

Global Cardiovascular Application Market To Expand At A Notable CAGR Of 7.24% During The Forecast Period
Market Overview:
Rapid advancement in technology is aiding the healthcare sector for the development of high-tech medical devices that can be used to ensure proper functioning of vital organs. Cardiovascular application includes the use of synthetic materials and advanced medical devices to help control abnormal functioning of the heart. Market Research Future (MRFR) has published a report stating that the global cardiovascular application market is market to expand at a notable CAGR of 7.24% during the forecast period of 2014-2023 and reach the valuation of USD 36730.5 Mn by the end of 2023.

Market Drivers and Restraints:
Increasing prevalence of cardiovascular diseases caused due to changing lifestyle and rapid rise in geriatric population are inducing high demand for advanced medical devices, resulting in the significant expansion of the global cardiovascular application market. The introduction of upgraded versions of pacemakers that can be integrated with smartphones to keep a real-time check on the functioning of the heart is impacting positively on the growth of the global cardiovascular application market. However, lack of awareness regarding advanced medical devices, high cost of treatment and medical devices and poor healthcare facilities in the underdeveloped regions are likely to pose potential threat for the growth of the global cardiovascular application market during the forecast period.
Market Segmentation:
The global cardiovascular application market has been segmented on the basis of devices and end users. Based on devices, the cardiovascular application market has been segmented into cardiac pacemaker, cardiac defibrillators, cardiac monitors, and others. The cardiac monitors segment is sub-segmented into resting ECG, ECG monitors, holter monitors, implantable loop recorder, and others. The cardiac defibrillator segment is sub-segmented into implantable cardioverter defibrillator and external defibrillator. The cardiac pacemaker segment is sub-segmented into implantable cardiac pacemaker and external cardiac pacemaker. The implantable cardiac pacemaker sub-segment includes single-chamber pacemakers, dual-chamber pacemakers, and biventricular pacemakers. 
Based on end users, the cardiovascular application market is segmented into cardiac care centers, ambulatory centers & home care, academic institutes, and others. 
Regional Analysis:
Geographically, the global cardiovascular application market has been segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas account for a major market share in the global cardiovascular application market owing to the rapid development of advanced medical devices in the well-developed healthcare sector of this region and increasing incidences suffering from cardiovascular disorders as a result of changing lifestyle. 
The cardiovascular application market in the Europe region is expanding at a noteworthy growth rate due to rise in prevalence of diabetes and cardiovascular diseases and high healthcare expenditure by the population in this region. The Asia Pacific region is projecting fastest growth in the global cardiovascular application market due to the increasing government support for development of affordable treatments and rise in adoption of advanced cardiovascular devices in the emerging economies in this region. The cardiovascular application market is projecting slow growth in the Middle East and Africa region due to the unavailability of proper health care services in the underdeveloped areas of this region.

Industry Updates:
In September 2018, researchers from Duke Clinical Research Institute have collaborated with Cerner, a developer of healthcare solution for the creation of web-based risk calculator application to assist doctors in calculating their patients' risk for atherosclerotic cardiovascular disease (ASCVD).
In September 2018, St. Jude Medical has launched a new diagnosis device named Confirm Loop Recorder. This device is implanted in the body at an angle near the heart in order to monitor abnormal heartbeats in patients with cardiovascular disorders.
In June 2018, a team of cardiologist from Mediclinic Panorama, Cape town have successfully implanted a latest pacemaker technology in an 84-year-old patient. This pacemaker, named 'His Bundle Pacing' (HBP), aids the patient in regaining synchronous contraction of both ventricles like a normal heart, unlike traditional pacemaker.
Key Players:
Some of the prominent players that are profiled by MRFR in the report on the global cardiovascular application market are Abbott (the U.S.), General Electric Company (the U.S.), Medtronic (Ireland), Boston Scientific Corporation (the U.S.), KONINKLIJKE PHILIPS N.V. (The Netherlands), Terumo (Japan), Stryker Corporation (the U.S.), Edwards Lifesciences (the U.S.), Allergan Inc. (the U.S.), Smith & Nephew plc (the U.K), CR Bard Inc. (the U.S.), Sonova Holdings (Switzerland), and Dragerwerk AG & Co. KGa (Germany)
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Wednesday 18 March 2020

Diabetes Monitors Market -Size, Global growth and Forecast to 2023

Market HighlightsDiabetes is a metabolic disease that occurs when blood glucose level is too high either due to inadequate insulin production or because of low response towards insulin. The three most common type of diabetes are Type 1, Type 2, and gestational diabetes. Other less common type includes cystic fibrosis-related diabetes, and monogenic diabetes. The frequent blood glucose monitoring is critical for diabetic management, as the maintenance of standard glucose level, i.e. 4–8 mM, is the only way that a diabetic person can lead a healthy lifestyle. According to WHO, global prevalence of diabetes has risen from 4.7% to 8.5% in 2014. It is also estimated that around 1.6 million deaths have occurred in 2015 due to diabetes worldwide.
Rise in technological innovations, huge research funding for diabetes diagnosis and treatment, increasing prevalence and incidence of diabetes, rising approval from regulatory bodies, and increasing global obesity population. However, high cost associated with diagnosis and treatment of diabetes, and stringent reimbursement policies may hinder the growth of market to an extent.
It is estimated that diabetes monitors market is expected to grow at a CAGR 8.3% during the forecast period 2017-2023.
Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “diabetes monitors market research report–Global forecast till 2023.”
Major Key Players in Global Diabetes Monitors MarketSome of key the players in the market are Panasonic, Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd , Medtronic, LifeScan, Inc., Sanofi, and others.

The global diabetes monitors market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas is the leading market across the globe on account of increasing patient population. As per the National Diabetes Statistics Report suggested by Centers for Disease Control and Prevention, it is found that 9.4% of the U.S. population i.e. 30.3 million people had diabetes in 2015.
Europe accounts for the second largest market in the world. Europe consist of two regions namely Western Europe and Eastern Europe. Western Europe holds the major share of the market, which is majorly contributed by Germany, the U.K., and France. The increasing government support for development of the healthcare domain drives the European market.
Asia Pacific region is projected to be the fastest growing region during the forecast period. Increasing need for cost-effective glucose monitoring devices, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region.
The Middle East and Africa holds the least share of the global market owing to the presence of poor and slow developing countries, especially, in African region.

Segmentation
The global diabetes monitors market is segmented on the basis of sample, type, component, and end-users.
On the basis of sample, the market is segmented into blood samples, sweat samples, urine samples, and others.
On the basis of type, the market is classified into point sample test based glucose monitors, continuous glucose monitors, and enzyme free sensor based glucose monitors. Continuous glucose monitors are further segmented into disposable sensor based CGM, and re-usable sensor based CGM.
On the basis of components, the market is classified into lancet, glucose test strips, and sensors. Sensors are further segmented into enzyme-based sensors, and enzyme-free sensors
On the basis of end -users, the market is segmented into diagnostic clinics, hospitals, and home.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781
Posted by at No comments:
Labels: , ,

Thursday 12 March 2020

Intracranial Pressure (ICP) Monitoring Market trends and Regional Demand by forecast to 2023

Market Synopsis
Market Research Future (MRFR) postulates that the global intracranial pressure (ICP) monitoring market is likely to exhibit 7.1% CAGR during the forecast period (2018-2024) due to the increasing prevalence of neurovascular diseases like brain aneurysm and arteriovenous malformations. Intracranial pressure monitoring devices are especially designed to measure the pressure within the cranium which is caused by accident and trauma. Such devices are generally used to treat traumatic brain injury. ICP measures the pressure in the skull by placing a small probe in the skull. The probe is further attached at the other end to a monitor. The device helps to sense the pressure caused inside the skull and transports the measurements to a recording device.

Market Potential and Pitfalls
With the increasing incidences of neurovascular diseases like brain aneurysm and arteriovenous malformations, the global intracranial pressure (ICP) monitoring market is predicted to foster during the forecast period. The increased expenditure on healthcare coupled with the strong demand for therapeutics is some of the chief factors propelling the market growth across the globe. The market is slated to exhibit a sturdy growth rate owing to the introduction of favorable reimbursement policies which aim towards the betterment of the public. Moreover, the surging biotechnology sector is likely to cause a shift in the sector and result in the growth of ICP monitoring market.
With the emergence of advanced ICP monitoring devices, the limitations of earlier devices like leveling and de-bubbling of fluid-filled systems and shift in baseline pressure have been eliminated. Advanced monitors enable surgeons to monitor a patient closely and offer effective treatment. The non-invasive ICP monitoring methods do not measure absolute ICP. Therefore, the validation and development of non-invasive intracranial pressure which is capable of measuring absolute ICP device will create great opportunities for the growth of the ICP monitor market. The rising prevalence of stroke and traumatic surgeries has highly influenced the intracranial pressure monitoring market across the globe. Moreover, the upswing in cases of brain surgeries in adults as well as children has triggered the demand for ICP monitors.
On the contrary, high procedural costs of such devices coupled with the dearth of skilled personnel are some of the concerns anticipated to deter the market growth in the coming years.

Global Intracranial Pressure (ICP) Monitoring Market: Segmental Analysis
The global intracranial pressure (ICP) monitoring market has been segmented on the basis of technique, route of intervention, application, device, and end-user.
By mode of route of intervention, the global intracranial pressure (ICP) monitoring market has been segmented into epidural and intraventricular sensor.
By mode of technique, the global intracranial pressure (ICP) monitoring market has been segmented into non-invasive and invasive.
By mode of devices, the global intracranial pressure (ICP) monitoring market has been segmented into subarachnoid screw, intraventricular catheter, non-invasive ICP monitors, and epidural sensors.
By mode of applications, the global intracranial pressure (ICP) monitoring market has been segmented into intracerebral hemorrhage, traumatic brain injury, meningitis, and subarachnoid hemorrhage. Among these, the traumatic brain injury segment is anticipated to hold a significant share in the global market due to its vast prevalence globally.
By mode of end-users, the global intracranial pressure (ICP) monitoring market has been segmented into trauma centers and hospitals & clinics.

Regional Insights
Geographically, the intracranial pressure (ICP) monitoring market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.
Among all the regions, the American region is considered to lead the global intracranial pressure (ICP) monitoring market. The growth is credited to the increasing number of patients suffering from moderate to severe brain injury. Moreover, awareness regarding neurodegenerative disease coupled with the constant initiatives undertaken by the government for offering a better infrastructure is predicted to contribute to the market growth in this region.
The Asia Pacific region is considered to expand at the fastest rate owing to the presence of a large patient pool suffering from brain disorders. Moreover, government initiatives and the presence of well-established critical care centers and hospitals are further estimated to boost the market in this region.

Industry Updates
June 01, 2018: A company dedicated to offering cost-effective mobile solutions for ICP, Branchpoint Technologies has recently announced that the U.S. FDA has granted 510(k) clearance for its AURA ICP Monitoring System. The system comprises a fully wireless and implantable ICP sensor, enabling truly mobile ICP monitoring in patients with brain-injury.

Competitive Dashboard
The prominent players operating in the global intracranial pressure (ICP) monitoring market are Terumo Corporation (U.S.), Spiegelberg GmbH & Co. KG (Germany), DePuy Synthes (U.S.), Medtronic Plc (Ireland), RAUMEDIC Inc. (Germany), Sophysa SA (France), Natus Medical Incorporated (U.S.), Boston Neurosciences (U.S.), and Integra LifeSciences Corporation (U.S.).

You can See More Report :
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: ,

Healthcare Contract Manufacturing Market- Latest trends, Industry Updates and Regional Forecast to 2023

Overview:
The healthcare contract manufacturing market is benefiting much from the growing demand for medicine supplies which is facing a severe crisis from the pending expiration of a lot of generic drugs. The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers. From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides. The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR). The report ensures a detailed analysis of the segments and driving factors that can assist the market in growth over the review period.
Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the market growth during the forecast period. Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion. Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up. Factors such as these are bound to boost the global from drug development to drug manufacturing market.
On the flip side, controlling third parties is quite complex which many manufacturers prefer to avoid. At the same time, clinical trials are becoming more exhaustive and tangled which can deter the healthcare contract manufacturing market from having the expected growth rate over the review period.
Segmentation:
The global healthcare contract manufacturing market can be segmented by type, service type, and industry.
Based on the type, the healthcare contract manufacturing market can be segmented into sterile and non-sterile.
On the basis of the service type, the healthcare contract manufacturing market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.
Industry-wise segmentation of the healthcare contract manufacturing market includes pharmaceutical, medical device, and biopharmaceutical.
Regional Analysis:
Region-specific analysis of the global healthcare contract manufacturing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas is in charge of the global healthcare contract manufacturing market. With rising investment in healthcare, the focus is mainly on improving healthcare infrastructure and upgrading research institutions for better technology and others. Subsequently, manufacturers are now relying more on the advanced instruments they have put in use in their factories and manufacturing capabilities.
Europe assumes the second position in the market and the credit goes to the increased expenditure initiated by the regional governments. The reports published by the Organization for Economic Co-operation and Development (OECD) discloses that Germany spent USD 321 billion in 2014 in the healthcare sector which is a significant marker of the progress the regional market is making at present.
The APAC is the fastest growing market as major regional economies such as China and India are considerably investing to better their healthcare facilities to lure in patients from all over the world as a part of their medical tourism planning.
Competitive Analysis:
Some of the key players in this healthcare contract manufacturing market are Aesica Pharmaceuticals, Boehringer Ingelheim, AbbVie, Grifols International, S.A, Evonik Industries, Lonza Ag, Catalent, Benchmark Electronics, Flex Ltd, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Teva Pharmaceutical Industries, Patheon, Mylan, Vetter Pharma International, and others.
In August 2018, Catalent completed their move to acquire Juniper. This would give the former a new and robust European base to function. Catalent, as the parent company of Juniper, would ensure the supply of Crinone marketed by Merck KGaA.
In January 2018, Intermountain Healthcare declared their plan to create a non-profit generic drug company as a direct manufacturer or contract manufacturer in collaboration with Ascension, SSM Health, and Trinity Health.

You can See More Report :


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Tuesday 3 March 2020

Cystic Fibrosis (CF) Therapeutics Market Outlook 2020 | Global Industry Growth & Demand by 2025

Cystic Fibrosis (CF) Therapeutics Market Overview: 
Cystic fibrosis is a genetic disorder that commonly affects the lungs and also the other secretory glands such as pancreas, liver, kidneys and intestine. As per the report that has been published by Market Research future (MRFR), the global cystic fibrosis market is anticipated to expand significantly at a CAGR of 13.5% during the forecast period of 2016-2022.
Market Drivers and Restraints: 
The incidences of diseases caused due to genetic disorders owing to mutation in human genes are increasing rapidly. The prevalence of such diseases is generating high demand for effective treatments. Increased research and development activities in order to introduce new drugs and highly effective treatments for cystic fibrosis owing to the high prevalence of this disease is leading to the significant growth of the global cystic fibrosis market.

Development of various diagnostic tests to detect genetically inherited cystic fibrosis and high investment in R&D are projecting positive impact on the expansion of the global cystic fibrosis market. Initiatives such as newborn screening programs to diagnose cystic fibrosis at young age and introduction of new drugs with higher efficacy are fueling the growth of the global Cystic Fibrosis (CF) Therapeutics Market.

However, increase in the complexity of disease and high cost of treatment along with lack of awareness are likely to impact negatively on the growth of the global cystic fibrosis market during the forecast period. 
Market Segmentation:
The global cystic fibrosis market has been segmented on the basis of treatment. Based on treatment, the cystic fibrosis market is segmented into medication, devices and other treatments. The medication segment accounts for the largest share of 76.4% in the global cystic fibrosis market owing to the high demand of efficient medication to treat cystic fibrosis and increased research for developing new drugs by the medical institutes and pharmaceutical companies in the global market.
Regional Analysis:
The global cystic fibrosis market is geographically segmented into North America, Europe, Asia Pacific and the Middle East and Africa. The North America region is dominating the global cystic fibrosis market owing to the high prevalence of cystic fibrosis in this region.
Increasing incidences of cystic fibrosis and rise in demand for proper treatment are driving the cystic fibrosis market in the Europe region. The Asia Pacific region is projecting steady growth in the global cystic fibrosis market owing to the low prevalence of this disease in this region.
The Middle East and Africa region accounts for the least share in the global cystic fibrosis market owing to the lack of awareness and poor healthcare facilities in the underdeveloped area of this region. 
Industry Updates:
In August 2018, an independent advisory committee by the Federal government has announced that a new drug, Orkambi, will soon be subsidized and listed on the Pharmaceutical Benefits Scheme and will be made available for public use. 
Key Players:
Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, Genentech, Pharmaxis, Chiesi Farmaceutici, Forest Laboratories and others.     


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)